These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 29510423)
41. A follow up on the feasibility after national implementation of magnesium sulfate for neuroprotection prior to preterm birth. Hellström S; Jonsdotter A; Jonsson M; Pettersson K; Saltvedt S; Herbst A; Ågren J; Ådén U; Domellöf M; Hagberg H; Carlsson Y Acta Obstet Gynecol Scand; 2023 Dec; 102(12):1741-1748. PubMed ID: 37680134 [TBL] [Abstract][Full Text] [Related]
42. Comparison of Cerebral Palsy Severity Between 2 Eras of Antenatal Magnesium Use. Stetson BT; Buhimschi CS; Kellert BA; Hay K; Buhimschi IA; Maitre NL JAMA Pediatr; 2019 Feb; 173(2):188-190. PubMed ID: 30508016 [TBL] [Abstract][Full Text] [Related]
47. Antenatal Magnesium Sulfate Is Not Associated With Improved Long-Term Neurodevelopment and Growth in Very Low Birth Weight Infants. Jeon GW; Ahn SY; Kim SM; Yang M; Sung SI; Sung JH; Oh SY; Roh CR; Choi SJ; Chang YS J Korean Med Sci; 2023 Nov; 38(44):e350. PubMed ID: 37967876 [TBL] [Abstract][Full Text] [Related]
48. Childhood neurodevelopment after spontaneous versus indicated preterm birth. Nuss EE; Spiegelman J; Turitz AL; Gyamfi-Bannerman C Am J Obstet Gynecol MFM; 2020 May; 2(2):100082. PubMed ID: 33345968 [TBL] [Abstract][Full Text] [Related]
49. Antenatal magnesium sulfate for both tocolysis and fetal neuroprotection in premature rupture of the membranes before 32 weeks' gestation. Jung EJ; Byun JM; Kim YN; Lee KB; Sung MS; Kim KT; Shin JB; Jeong DH J Matern Fetal Neonatal Med; 2018 Jun; 31(11):1431-1441. PubMed ID: 28391733 [TBL] [Abstract][Full Text] [Related]
50. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. Rouse DJ; Hirtz DG; Thom E; Varner MW; Spong CY; Mercer BM; Iams JD; Wapner RJ; Sorokin Y; Alexander JM; Harper M; Thorp JM; Ramin SM; Malone FD; Carpenter M; Miodovnik M; Moawad A; O'Sullivan MJ; Peaceman AM; Hankins GD; Langer O; Caritis SN; Roberts JM; N Engl J Med; 2008 Aug; 359(9):895-905. PubMed ID: 18753646 [TBL] [Abstract][Full Text] [Related]
51. Preterm premature rupture of membranes at 22-25 weeks' gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2). Lorthe E; Torchin H; Delorme P; Ancel PY; Marchand-Martin L; Foix-L'Hélias L; Benhammou V; Gire C; d'Ercole C; Winer N; Sentilhes L; Subtil D; Goffinet F; Kayem G Am J Obstet Gynecol; 2018 Sep; 219(3):298.e1-298.e14. PubMed ID: 29852153 [TBL] [Abstract][Full Text] [Related]
53. Magnesium sulfate for neuroprotection in patients at risk for early preterm delivery: not yet. Sibai BM Am J Obstet Gynecol; 2011 Oct; 205(4):296-7. PubMed ID: 22083053 [No Abstract] [Full Text] [Related]
54. [Neuroprotection for preterm infants with antenatal magnesium sulphate]. Marret S; Ancel PY J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1418-1433. PubMed ID: 28166926 [TBL] [Abstract][Full Text] [Related]
56. Prenatal Therapy with Magnesium Sulfate and Its Correlation with Neonatal Serum Magnesium Concentration. García Alonso L; Pumarada Prieto M; González Colmenero E; Concheiro Guisán A; Suárez Albo M; Durán Fernández-Feijoo C; González Durán L; Fernández Lorenzo JR Am J Perinatol; 2018 Jan; 35(2):170-176. PubMed ID: 28854447 [TBL] [Abstract][Full Text] [Related]